Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.990 | 5.990 | 0.000 |
Stocks | 96.590 | 96.590 | 0.000 |
Bonds | 0.540 | 0.540 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.453 | 20.566 |
Price to Book | 7.067 | 4.169 |
Price to Sales | 4.123 | 2.466 |
Price to Cash Flow | 20.614 | 17.017 |
Dividend Yield | 0.900 | 1.350 |
5 Years Earnings Growth | 25.436 | 13.676 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 77.930 | 94.945 |
Industrials | 6.450 | 2.553 |
Technology | 6.230 | 2.823 |
Consumer Cyclical | 5.160 | 9.755 |
Communication Services | 3.390 | 2.883 |
Utilities | 0.710 | 2.432 |
Real Estate | 0.050 | 2.808 |
Financial Services | 0.040 | 10.154 |
Consumer Defensive | 0.040 | 3.729 |
Number of long holdings: 45
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.29 | 767.76 | +1.35% | |
SPDR S&P Biotech | US78464A8707 | 8.02 | 91.28 | +1.64% | |
Novo Nordisk B | DK0062498333 | 6.78 | 589.2 | -20.72% | |
Intuitive Surgical | US46120E6023 | 5.32 | 524.43 | +0.10% | |
UnitedHealth | US91324P1021 | 4.95 | 500.13 | +2.22% | |
Amgen | US0311621009 | 4.58 | 263.38 | +0.84% | |
HCA | US40412C1018 | 3.99 | 303.62 | +2.05% | |
Boston Scientific | US1011371077 | 3.97 | 88.95 | +0.33% | |
Universal Health Services | US9139031002 | 3.10 | 180.11 | +2.45% | |
Vertex | US92532F1003 | 2.99 | 397.27 | +0.16% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital India Medium and Small Cap | 15.29B | 29.54 | 22.79 | 11.74 | ||
Capital Asia Pacific Mega Trend Bal | 621.03M | 21.65 | -1.53 | 2.62 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review